Antal Rohit Desai - Nov 14, 2022 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
Director, 10%+ Owner
Signature
/s/ Antal Rohit Desai
Stock symbol
PRCT
Transactions as of
Nov 14, 2022
Transactions value $
$0
Form type
4
Date filed
11/16/2022, 03:31 PM
Previous filing
Sep 13, 2022
Next filing
Dec 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Other $0 -1.73M -19.83% $0.00 6.99M Nov 14, 2022 By White Tailed Ptarmigan, LP F1, F2
holding PRCT Common Stock 27K Nov 14, 2022 By Kestrel Fund, L.P. F1, F3
holding PRCT Common Stock 172K Nov 14, 2022 By Mallard Fund, L.P. F1, F3
holding PRCT Common Stock 88.2K Nov 14, 2022 By The 2:22 DNA Trust F3, F4
holding PRCT Common Stock 54.6K Nov 14, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Antal Desai, a member of the Issuer's board of directors, and Kent McGaughy, Jr., each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the "CPMG Funds") Mr. Desai disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein. Kent McGaughy, Jr., CPMG, Inc. and White Tailed Ptarmigan, LP jointly report their beneficial ownership of these shares on a separate Form 4.
F2 On November 14, 2022, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 233,056 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13.
F3 Includes shares previously held indirectly through White Tailed Ptarmigan, LP, which were distributed on a pro rata basis, for no consideration, on November 14, 2022, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13.
F4 Mr. Desai and his spouse serve as co-trustees of The 2:22 DNA Trust. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by The 2:22 DNA Trust except to the extent of any pecuniary interest therein.